Kelly Airiau

Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death

Sandrine Eimer, Marc‐Antoine Belaud‐Rotureau, Kelly Airiau et al. · Cancer Biology & Therapy · 2011 · 67 citations

Life Sciences, Oncology, Pharmacology +17

PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor

Kelly Airiau, F-X Mahon, Marina Josselin et al. · Cell Death and Disease · 2013 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures

Sandrine Eimer, Frédéric Dugay, Kelly Airiau et al. · Neuro-Oncology · 2012 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

The stem cell factor–c-KIT pathway must be inhibited to enable apoptosis induced by BCR–ABL inhibitors in chronic myelogenous leukemia cells

Françis Belloc, Kelly Airiau, Marie Jeanneteau et al. · Leukemia · 2009 · 41 citations

Life Sciences, Cell Biology, Oncology +16

ABT-737 increases tyrosine kinase inhibitor–induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34+ CD38− population to imatinib

Kelly Airiau, François‐Xavier Mahon, Marina Josselin et al. · Experimental Hematology · 2012 · 32 citations

Medicine, Hematology, Oncology +15